BGM-2121
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BGM-2121, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BGM-2121 in Patients With Advanced Solid Tumors [Phase 1]